New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
High out-of-pocket costs hindering treatment of diabetes

High out-of-pocket costs hindering treatment of diabetes

by University of MichiganHigh out-of-pocket costs hindering treatment of diabetes. Credit: Jacob Dwyer/Michigan MedicineActively managing diabetes is crucial to preventing long-term health compli
Diabetes & Endocrinology March 14,2024
High out-of-pocket costs hindering treatment of diabetes

High out-of-pocket costs hindering treatment of diabetes

by University of MichiganHigh out-of-pocket costs hindering treatment of diabetes. Credit: Jacob Dwyer/Michigan MedicineActively managing diabetes is crucial to preventing long-term health compli
Diabetes & Endocrinology March 14,2024
ACR: walking each day may cut risk for TKA over five years

ACR: walking each day may cut risk for TKA over five years

(HealthDay)—For individuals with knee osteoarthritis (OA), replacing time not walking with walking at moderate-to-vigorous intensity is associated with reduced risk for total knee arthroplasty (TKA) o
Arthritis and Rheumatism March 14,2024
ACR: walking each day may cut risk for TKA over five years

ACR: walking each day may cut risk for TKA over five years

(HealthDay)—For individuals with knee osteoarthritis (OA), replacing time not walking with walking at moderate-to-vigorous intensity is associated with reduced risk for total knee arthroplasty (TKA) o
Arthritis and Rheumatism March 14,2024
Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

by Bram Sable-Smith, KFF Health NewsCredit: Christina Morillo from PexelsWhen Phyllisa Deroze was told she had diabetes in a Fayetteville, North Carolina, emergency department years ago, she was hande
Diabetes & Endocrinology March 14,2024
Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

by Bram Sable-Smith, KFF Health NewsCredit: Christina Morillo from PexelsWhen Phyllisa Deroze was told she had diabetes in a Fayetteville, North Carolina, emergency department years ago, she was hande
Diabetes & Endocrinology March 14,2024
Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

by University of Eastern FinlandTransition of patients between contact types by usual in-person service use frequency groups Groups based on in-person contact during 16 Mar 2017 to 15 Mar 2020: A
Diabetes & Endocrinology March 14,2024
Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

by University of Eastern FinlandTransition of patients between contact types by usual in-person service use frequency groups Groups based on in-person contact during 16 Mar 2017 to 15 Mar 2020: A
Diabetes & Endocrinology March 14,2024
ABT-494 effective for patients with rheumatoid arthritis

ABT-494 effective for patients with rheumatoid arthritis

(HealthDay)—A novel selective JAK-1 inhibitor, ABT-494, is effective for rheumatoid arthritis (RA) patients with inadequate response to methotrexate (MTX) or to at least one anti-tumor necrosis factor
Arthritis and Rheumatism March 14,2024
ABT-494 effective for patients with rheumatoid arthritis

ABT-494 effective for patients with rheumatoid arthritis

(HealthDay)—A novel selective JAK-1 inhibitor, ABT-494, is effective for rheumatoid arthritis (RA) patients with inadequate response to methotrexate (MTX) or to at least one anti-tumor necrosis factor
Arthritis and Rheumatism March 14,2024
For diabetes and liver cancer, study suggests new screening guidelines

For diabetes and liver cancer, study suggests new screening guidelines

by Krista Conger,Stanford University Medical CenterCollagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—ar
Diabetes & Endocrinology March 14,2024
For diabetes and liver cancer, study suggests new screening guidelines

For diabetes and liver cancer, study suggests new screening guidelines

by Krista Conger,Stanford University Medical CenterCollagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—ar
Diabetes & Endocrinology March 14,2024
Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

by Delthia Ricks , Medical XpressTeplizumab delays type 1 diabetes (T1D) in at-risk individuals in TN10 trial, but participants respond differently to the treatment. Systemic, non-pathogenic antibody
Diabetes & Endocrinology March 14,2024
Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

by Delthia Ricks , Medical XpressTeplizumab delays type 1 diabetes (T1D) in at-risk individuals in TN10 trial, but participants respond differently to the treatment. Systemic, non-pathogenic antibody
Diabetes & Endocrinology March 14,2024
3D printing a lightweight knee brace for the elderly

3D printing a lightweight knee brace for the elderly

by Nanyang Technological UniversityCentre for Orthopaedics chairman and CEO Dr Jeffery Chew helping Teo Lee Le, his patient who had two knee replacements, to wear the X-Brace. Credit: Nanyang Tec
Arthritis and Rheumatism March 14,2024
3D printing a lightweight knee brace for the elderly

3D printing a lightweight knee brace for the elderly

by Nanyang Technological UniversityCentre for Orthopaedics chairman and CEO Dr Jeffery Chew helping Teo Lee Le, his patient who had two knee replacements, to wear the X-Brace. Credit: Nanyang Tec
Arthritis and Rheumatism March 14,2024
Under-the-skin implant could treat type I diabetes

Under-the-skin implant could treat type I diabetes

by David Nutt,Cornell UniversityDesign of the SHEATH system.a, Schematic illustrating the creation of the vascularized subcutaneous site achieved by implantation of a catheter 4–6 weeks be
Diabetes & Endocrinology March 14,2024
Under-the-skin implant could treat type I diabetes

Under-the-skin implant could treat type I diabetes

by David Nutt,Cornell UniversityDesign of the SHEATH system.a, Schematic illustrating the creation of the vascularized subcutaneous site achieved by implantation of a catheter 4–6 weeks be
Diabetes & Endocrinology March 14,2024
Single 'smart' insulin injection regulates glucose levels in mice and minipigs up to one week

Single 'smart' insulin injection regulates glucose levels in mice and minipigs up to one week

by Bob Yirka , Medical XpressDually glucose-responsive complex for insulin delivery. Schematic of complex formation and insulin release with dual glucose-responsive mechanisms. The negatively charged
Diabetes & Endocrinology March 14,2024
Single 'smart' insulin injection regulates glucose levels in mice and minipigs up to one week

Single 'smart' insulin injection regulates glucose levels in mice and minipigs up to one week

by Bob Yirka , Medical XpressDually glucose-responsive complex for insulin delivery. Schematic of complex formation and insulin release with dual glucose-responsive mechanisms. The negatively charged
Diabetes & Endocrinology March 14,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com